EZH2 in Triple Negative Breast Cancer @Ramon_Parsons @IcahnMountSinai

EZH2 in Triple Negative Breast Cancer @Ramon_Parsons @IcahnMountSinai

Mount Sinai Health System

3 months
48 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Ramon Parsons, MD, PhD @Ramon_Parsons of @IcahnMountSinai discusses a novel agent that degrades a protein called EZH2 that drives the growth of triple negative breast cancer in cancer cell lines and live models. This research also showed that the agents which inhibit the enzymatic activity of EZH2 but do not degrade EZH2 did not work in triple negative breast cancer.
Up Next Autoplay